Deciphera Pharmaceuticals Inc

+0.01 (+0.04%)
7:21:26 PM EDT: $25.48 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.20B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$46.12 Million
Adjusted EPS-$0.55
See more estimates
10-Day MA$25.15
50-Day MA$18.83
200-Day MA$15.15
See more pivots

Deciphera Pharmaceuticals Inc Stock, NASDAQ:DCPH

200 Smith Street, 6th floor, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.209.6400
Number of Employees: 355


Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.